Intra-Cellular Therapies, Inc. Quarterly Operating Income (Loss) in USD from Q3 2012 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Intra-Cellular Therapies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q3 2024.
Intra-Cellular Therapies, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$38.8M, a 30.7% decline year-over-year.
Intra-Cellular Therapies, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$122M, a 29.6% increase year-over-year.
Intra-Cellular Therapies, Inc. annual Operating Income (Loss) for 2023 was -$159M, a 39.5% increase from 2022.
Intra-Cellular Therapies, Inc. annual Operating Income (Loss) for 2022 was -$264M, a 7.72% increase from 2021.
Intra-Cellular Therapies, Inc. annual Operating Income (Loss) for 2021 was -$286M, a 23.6% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$122M	-$38.8M	-$9.14M	-30.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-30
Q2 2024	-$112M	-$27.7M	+$19.5M	+41.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$132M	-$21M	+$27.4M	+56.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	-$159M	-$34.1M	+$13.3M	+28.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	-$173M	-$29.7M	+$25.9M	+46.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-30
Q2 2023	-$199M	-$47.2M	+$40.7M	+46.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$239M	-$48.4M	+$24.3M	+33.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	-$264M	-$47.4M	+$38.6M	+44.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	-$302M	-$55.6M	+$21.7M	+28.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	-$324M	-$87.9M	-$18.8M	-27.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	-$305M	-$72.7M	-$19.4M	-36.5%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	-$286M	-$86M	-$24.7M	-40.2%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	-$261M	-$77.3M	-$21.4M	-38.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	-$240M	-$69.1M	-$4.27M	-6.58%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	-$235M	-$53.2M	-$4.13M	-8.42%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$231M	-$61.3M	-$19.6M	-46.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	-$212M	-$55.9M	-$19.6M	-53.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	-$192M	-$64.9M	-$25.7M	-65.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	-$166M	-$49.1M	-$12.4M	-33.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	-$154M	-$41.8M	+$854K	+2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	-$155M	-$36.4M	+$7.02M	+16.2%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	-$162M	-$39.2M	-$2.86K	-0.01%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$162M	-$36.7M	+$388K	+1.05%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$162M	-$42.6M	-$9.91M	-30.3%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018	-$152M	-$43.4M	-$19.6M	-82.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	-$133M	-$39.2M	-$20.5M	-110%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	-$112M	-$37.1M	-$9.33M	-33.6%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	-$103M	-$32.7M	-$4.68M	-16.7%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-02
Q3 2017	-$98.2M	-$23.8M	+$6.43M	+21.3%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	-$105M	-$18.6M	+$12.9M	+41%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-02
Q1 2017	-$118M	-$27.8M	+$744K	+2.61%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-03
Q4 2016	-$118M	-$28M	+$1.34M	+4.56%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-27
Q3 2016	-$120M	-$30.2M	+$2.16M	+6.69%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016	-$122M	-$31.5M	-$9.85M	-45.4%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-09
Q1 2016	-$112M	-$28.5M	-$6.1M	-27.2%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-10
Q4 2015	-$106M	-$29.4M	-$14.1M	-92%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-01
Q3 2015	-$91.7M	-$32.3M	-$25.8M	-397%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$65.9M	-$21.7M	-$17.1M	-370%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-04
Q1 2015	-$48.8M	-$22.4M	-$17.8M	-390%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-28
Q4 2014	-$31M	-$15.3M	-$7.26M	-90.4%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-01
Q3 2014	-$23.7M	-$6.5M	-$1.72M	-35.9%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-05
Q2 2014	-$22M	-$4.61M	+$3.44M	+42.7%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-05
Q1 2014	-$25.4M	-$4.57M	+$826K	+15.3%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-30
Q4 2013	-$26.3M	-$8.03M			Oct 1, 2013	Dec 31, 2013	10-K	2016-02-25
Q3 2013		-$4.79M	-$2.56M	-115%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-03
Q2 2013		-$8.05M			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-12
Q1 2013		-$5.4M			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-05
Q3 2012		-$2.22M			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.